"The overall results, that substantially more individuals are on psychotropic medications is sobering and important. Understanding the reasons for this increase is the next critical goal," said Dr. Martha Sajatovic, Professor of Psychiatry at Case Western Reserve University School of Medicine and Director of the Neurological Outcomes Center, University Hospitals Case Medical Center. "The health care implications could be substantial given increasing financial constraints on individuals and health care funding entities."
Dr Sajatovic is professor of psychiatry at Case Western Reserve University School of Medicine in Cleveland and director of geropsychiatry at University Hospitals Case Medical Center in Cleveland.Dr Muzina reports that he is on the speakers' bureau for AstraZeneca, Bristol-Myers Squibb, Pfizer, Sepracor, and Wyeth; and that he is a member of the scientific advisory board for AstraZeneca.Dr Sajatovic reports that she has received research funding from AstraZeneca, GlaxoSmithKline, and the NIMH; and she is a consultant for GlaxoSmithKline, Cognition Group, and AstraZeneca.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.